Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06638554 · ClinicalTrials.gov registry record · NA
Integrating Telehealth to Advance Lung Cancer Screening
A NA study of Telemedicine and Decision Making, sponsored by Abramson Cancer Center at Penn Medicine.
- Recruiting
- Registry status
- NA
- Development phase
- 6,000
- Enrollment target
- 1
- Study location
NCT06638554 is a NA study of Telemedicine and Decision Making that is actively recruiting participants, run by Abramson Cancer Center at Penn Medicine. The registered enrollment target is 6,000 participants, above the 3,724-participant average among 18 other Telemedicine trials with a reported enrollment target (61% higher). The trial reports 1 study location across 1 state.
The verdict
NCT06638554, a NA study of Telemedicine and Decision Making, is actively recruiting participants, sponsored by Abramson Cancer Center at Penn Medicine.
- RECRUITING
- Registry status
- NA
- Development phase
- 6,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this pragmatic trial is to learn if telehealth strategies can increase shared decision-making (SDM) for lung cancer screening (LCS). It will also learn about the equity of these strategies by conducting non-inferiority analysis by race and sex. The main questions it aims to answer are: 1. Does patient outreach using synchronous and asynchronous telehealth strategies increase completion of SDM visits for LCS? 2. Is the effectiveness of these telehealth strategies similar by race and sex? The study uses a Sequential Multiple Assignment Randomized Trial (SMART) design and includes two stages of interventions. The first stage of intervention includes direct patient outreach with an invitation to schedule either a 1) telehealth SDM visit or 2) telehealth or in-person SDM visit. Participants that do not respond to the first stage interventions receive a text message reminder encouraging SDM visit completion with or without digital care coordination.
Conditions Studied
Interventions
- BEHAVIORAL Active Choice
- BEHAVIORAL Telehealth Only
- BEHAVIORAL Low Touch Strategy
- BEHAVIORAL High Touch Strategy
Study Locations (1)
Pennsylvania
- University of Pennsylvania - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6,000 participants |
| Start Date | 2024-07-09 |
| Est. Completion | 2027-01-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06638554
The ClinicalTrials.gov registry entry for NCT06638554 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 6,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 3,724-participant average among 18 other Telemedicine trials with a reported enrollment target (61% higher). The listed sponsor is Abramson Cancer Center at Penn Medicine, which has 402 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Telemedicine appearing as the primary indexed condition, and to 4 interventions - of which Active Choice is the first listed.
NCT06638554 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT06638554 about?
NCT06638554 is a clinical study titled "Integrating Telehealth to Advance Lung Cancer Screening". The goal of this pragmatic trial is to learn if telehealth strategies can increase shared decision-making (SDM) for lung cancer screening (LCS). It will also learn about the equity of these strategies by conducting non-inferiority analysis by race and sex. The main questions it aims to answer are: ...
What is the current status of trial NCT06638554?
This trial is currently recruiting. It is a NA study. The enrollment target is 6,000 participants. The study started on 2024-07-09. Estimated completion is 2027-01-31.
What conditions does trial NCT06638554 study?
This clinical trial studies the following conditions: Telemedicine, Decision Making, Early Detection of Cancer.
What interventions are being tested in trial NCT06638554?
The interventions under investigation include: Active Choice (BEHAVIORAL), Telehealth Only (BEHAVIORAL), Low Touch Strategy (BEHAVIORAL), High Touch Strategy (BEHAVIORAL).
Who is sponsoring clinical trial NCT06638554?
This trial is sponsored by Abramson Cancer Center at Penn Medicine, which has 402 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06638554 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Telemedicine
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Integrated Telemedicine Program Evaluation
RECRUITING · NA
-
Telemedicine Use in Preoperative Counseling for Endometrial Cancer Survivors
RECRUITING · NA
-
Sleep for Stroke Management and Recovery Trial
ACTIVE NOT RECRUITING · NA
-
Effect of Telemedicine on Physician-Patient Communication
COMPLETED · NA
-
Evaluation of Store-and-Forward Teledermatology Versus a Face-to-Face Assessment During a Skin Cancer Screening Event
COMPLETED · NA
-
Stroke Telemedicine Outpatient Prevention Program for Blood Pressure Reduction
COMPLETED · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.